Satellos Bioscience Inc.
- Last sale
- Nov 5, 2026 · -4.98%
- Market cap
- $97.24M
- 15.46M shares
- Filings
- 56
—
—
—FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−75.5% FY25 yoy
- $97.24M
- —
- —
- 3.5×
- -24.27%
- —
FY2025 figures · derived
Price
Nov 5, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $18,426,000 | reported | |
| FY 2024 | 2024-12-31 | $14,359,000 | reported |
Segments
Geography
LineFY2025ShareChange
Canada$31.01M97%−37.5%
Australia$669.00K2.1%−31.7%
USA$207.00K0.6%+42.8%
Total$31.89M
Pharmaceutical preparations
Satellos Bioscience Inc. is the 291st largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CATXPerspective Therapeutics, Inc.———$102.6MLEXXLexaria Bioscience Corp.$705.9K52.0%1,686.0%$102.4MUNCYUnicycive Therapeutics, Inc.———$101.1MCPIXCumberland Pharmaceuticals Inc$44.5M17.6%6.4%$98.4MNRXPNRX Pharmaceuticals, Inc.$1.2M—2,336.5%$97.8M
MSLESatellos Bioscience Inc. (this company)———$97.2M
NBPNovaBridge Biosciences———$95.8MPLYXPolaryx Therapeutics, Inc.———$94.2MANIXAnixa Biosciences Inc———$93.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Satellos Bioscience Inc. · CIK 1421642 · Engraved from SEC EDGAR